Acute interstitial nephritis due to statin and its class effect

Indian Journal of Nephrology

Volumn 25, Issue 1, 2015, Pages 54-56

  Annigeri, R ^a   Mani, R ^a  

^a APOLLO HOSPITALS   (India)

Author keywords

Acute interstitial nephritis; acute kidney injury; statins

Indexed keywords

ATORVASTATIN; COMPLEMENT COMPONENT C3; CREATINE KINASE; CREATININE; IMMUNOGLOBULIN M; MULTIVITAMIN; PREDNISOLONE; ROSUVASTATIN;

ACUTE HEART INFARCTION; ACUTE KIDNEY FAILURE; ADULT; ARTERIOSCLEROSIS; ARTICLE; CASE REPORT; CELL INFILTRATION; CREATINE KINASE BLOOD LEVEL; CREATININE BLOOD LEVEL; CROSS REACTION; DIABETES MELLITUS; DRUG EFFECT; DRUG RESPONSE; DRUG WITHDRAWAL; FATIGUE; HUMAN; HYPERLIPIDEMIA; INTERSTITIAL NEPHRITIS; KIDNEY BIOPSY; KIDNEY FUNCTION; MALE; MIDDLE AGED; NEPHROTOXICITY; STEROID THERAPY; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT DURATION;

EID: 84921633284     PISSN: 09714065     EISSN: 19983662     Source Type: Journal    
DOI: 10.4103/0971-4065.136883     Document Type: Article

References (14)

1. Cholesterol Treatment Trialists' (CTT) Collaborators, Mihaylova B, Emberson J, Blackwell L, Keech A, Simes J, et al. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: Metaanalysis of individual data from 27 randomised trials. Lancet 2012;380:581-90.
2. Deedwania P, Stone PH, Bairey Merz CN, Cosin Aguilar J, Koylan N, Luo D, et al. Effects of intensive versus moderate lipid lowering therapy on myocardial ischemia in older patients with coronary heart disease: Results of the Study Assessing Goals in the Elderly (SAGE). Circulation 2007;115:700-7.
3. Law M, Rudnicka AR. Statin safety: Systematic review. Am J Cardiol 2006;97:52C 60.
4. Mithani S, Kuskowski M, Slinin Y, Ishani A, McFalls E, Adabag S. Dose dependent effect of statins on the incidence of acute kidney injury after cardiac surgery. Ann Thorac Surg 2011;91:520-5.
5. Khanal S, Attallah N, Smith DE, Kline Rogers E, Share D, O'Donnell MJ, et al. Statin therapy reduces contrast induced nephropathy: An analysis of contemporary percutaneous interventions. Am J Med 2005;118:843-9.
6. Kasiske BL, Wanner C, O'Neill WC, National Lipid Association Statin Safety Task Force Kidney Expert Panel. An assessment of statin safety by nephrologists. Am J Cardiol 2006;97:82C 5.
7. Hippisley Cox J, Coupland C. Unintended effects of statins in men and women in England and Wales: Population based cohort study using the QResearch database. BMJ 2010;340:c2197.
8. Dormuth CR, Hemmelgarn BR, Paterson JM, James MT, Teare GF, Raymond CB, et al. Use of high potency statins and rates of admission for acute kidney injury: Multicenter, retrospective observational analysis of administrative databases. BMJ 2013;346:f880.
9. Roberts MD. CRESTOR (Rosuvastatin calcium) NDA 21-366 JUPITER. United States Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee, 2009. Available from: http://www.fda.gov/downloads/AdvisoryCommittees/Commit%20teesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugs%20AdvisoryCommittee/UCM193831.pdf [Last accesssed on 2014 Jul 01].
10. McMurray JJ, Dunselman P, Wedel H, Cleland JG, Lindberg M, Hjalmarson A, et al. Coenzyme Q10, rosuvastatin, and clinical outcomes in heart failure: A pre specified substudy of CORONA (controlled rosuvastatin multinational study in heart failure). J Am Coll Cardiol 2010;56:1196-204.
11. Ishikawa A, Kawarazaki H, Ando K, Fujita M, Fujita T, Homma Y. Renal preservation effect of ubiquinol, the reduced form of coenzyme Q10. Clin Exp Nephrol 2011;15:30-3.
12. Singh RB, Khanna HK, Niaz MA. Randomized, double blind placebocontrolled trial ofcoenzyme Q10 in chronic renal failure: Discovery of a new role. J Nutr Environ Med 2000;10:281-8.
13. Londrino F, Zattera T, Falqui V, Corbani V, Cavallini M, Stefanini T, et al. Rosuvastatin induced acute interstitial nephritis. Case Rep Nephrol Urol 2013;3:87-90.
14. van Zyl Smit R, Firth JC, Duffield M, Marais AD. Renal tubular toxicity of HMG CoA reductase inhibitors. Nephrol Dial Transplant 2004;19:3176-9.